Last edition
News about Global Pharma
BioMed X and Novo Nordisk Partner to Advance Oral Peptide Drug Delivery
BioMed X and Novo Nordisk’s partnership aims to address one of the most critical challenges in modern drug development: the efficient oral delivery of therapeutic peptides.
Global Pharma | 21/08/2025 | By Dineshwori | 656
LSPedia Partners with Spring Bio Solution to Advance Pharma Traceability in India
LSPedia has partnered with India-based Spring Bio Solution to expand global adoption of its OneScan pharmaceutical compliance and track-and-trace platform.
Global Pharma | 21/08/2025 | By Mrinmoy Dey | 247
NATCO Launches Tracleer Generic in US with Lupin
NATCO Pharma has announced the launch of Bosentan tablets for oral suspension (TFOS), 32mg, a generic version of Tracleer by Actelion Pharmaceuticals US Inc., in partnership with Lupin.
Global Pharma | 20/08/2025 | By Dineshwori | 346
Alembic Pharma Receives USFDA Final Approval for Macitentan Tablets, 10 mg
Alembic Pharmaceuticals Ltd. has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Macitentan Tablets, 10 mg.
Global Pharma | 20/08/2025 | By Dineshwori | 432
Senores Pharmaceuticals Appoints Manohar Lalge as President - Research & Development
Senores Pharmaceuticals Ltd. (SPL) has appointed Manohar Lalge as President – Research and Development.
Global Pharma | 20/08/2025 | By Dineshwori | 456
Pharma sector braces for tariff risks as US steps up trade actions: Report
India’s pharmaceutical industry may face fresh tariff challenges as the United States intensifies trade actions, according to a recent report. The development has raised concerns among Indian drugmakers, who already account for a significant share of the generic medicines supplied to the US market.
Global Pharma | 20/08/2025 | By Darshana | 218
AbbVie Announces Completion of Acquisition of Capstan Therapeutics
AbbVie has completed its acquisition of Capstan Therapeutics, bringing onboard Capstan’s tLNP platform and lead asset CPTX2309 to advance next-generation in vivo CAR-T therapies for autoimmune diseases.
Global Pharma | 20/08/2025 | By Mrinmoy Dey | 336
XtalPi has signed an MoU with South Korea’s Dong-A ST to co-develop novel therapies for immunological and inflammatory diseases using its AI-driven, automated drug discovery platform.
Global Pharma | 20/08/2025 | By Mrinmoy Dey | 138
Extrovis AG, Dr. Reddy's Partner to Roll Out CARAC 0.5 Percent Generic in US Market
Extrovis AG and Dr. Reddy's Laboratories have announced the launch of Fluorouracil Cream, 0.5 percent, an authorised generic and therapeutic equivalent of Carac (fluorouracil cream) 0.5 percent, in the US market.
Global Pharma | 19/08/2025 | By Dineshwori | 331
Indian contract development and manufacturing organisations (CDMOs) and CRDMOs are poised for improved profitability and healthier credit profiles, driven by a shifting supply chain landscape in the United States.
Global Pharma | 19/08/2025 | By Darshana | 290
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy